in ‘t Veld, Aliede E. http://orcid.org/0000-0001-6927-397X
Grievink, Hendrika W. http://orcid.org/0000-0002-5611-108X
van der Plas, Johan L. http://orcid.org/0000-0003-1259-4988
Eveleens Maarse, Boukje C. http://orcid.org/0000-0003-1763-3122
van Kraaij, Sebastiaan J. W. http://orcid.org/0000-0002-2465-1831
Woutman, Tess D.
Schoonakker, Mascha
Klarenbeek, Naomi B.
de Kam, Marieke L.
Kamerling, Ingrid M. C.
Jansen, Manon A. A.
Moerland, Matthijs http://orcid.org/0000-0002-8064-8426
Article History
Received: 26 September 2022
Accepted: 14 February 2023
First Online: 22 February 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the independent Ethics Committee “Medisch Ethische Toetsingscommissie van de Stichting Beoordeling Ethiek Biomedisch Onderzoek” (Assen, the Netherlands) on 13 May 2020. This trial is registered in the WHO International Clinical Trials Registry Platform (ICTRP) under study number NL8726. The study was performed in compliance with the Dutch laws on drug research in humans.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare that they have no conflict of interest.